NCT01448577View on ClinicalTrials.gov

"Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal Pancreatitis Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies"

UnknownOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Lipoprotein Lipase Deficiency
Trial Locations (2)

G7H 7P2

ECOGENE-21 Clinical Trial Center, Chicoutimi

G1V 4M6

La Clinique de Maladies Lipidiques de Quebec Inc. (CMLQ, Inc.), Québec

Sponsors
All Listed Sponsors
collaborator

The Clinical Trial Company

INDUSTRY

lead

Amsterdam Molecular Therapeutics

INDUSTRY

NCT01448577 - "Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal Pancreatitis Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies" | Biotech Hunter | Biotech Hunter